243 related articles for article (PubMed ID: 16168373)
1. HuR as a negative posttranscriptional modulator in inflammation.
Katsanou V; Papadaki O; Milatos S; Blackshear PJ; Anderson P; Kollias G; Kontoyiannis DL
Mol Cell; 2005 Sep; 19(6):777-89. PubMed ID: 16168373
[TBL] [Abstract][Full Text] [Related]
2. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation.
Lin FY; Chen YH; Lin YW; Tsai JS; Chen JW; Wang HJ; Chen YL; Li CY; Lin SJ
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2622-9. PubMed ID: 16990552
[TBL] [Abstract][Full Text] [Related]
3. The regulation of glucose transporter (GLUT1) expression by the RNA binding protein HuR.
Gantt KR; Cherry J; Richardson M; Karschner V; Atasoy U; Pekala PH
J Cell Biochem; 2006 Oct; 99(2):565-74. PubMed ID: 16639702
[TBL] [Abstract][Full Text] [Related]
4. mRNA openers and closers: modulating AU-rich element-controlled mRNA stability by a molecular switch in mRNA secondary structure.
Meisner NC; Hackermüller J; Uhl V; Aszódi A; Jaritz M; Auer M
Chembiochem; 2004 Oct; 5(10):1432-47. PubMed ID: 15457527
[TBL] [Abstract][Full Text] [Related]
5. Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
Sugihara M; Tsutsumi A; Suzuki E; Wakamatsu E; Suzuki T; Ogishima H; Hayashi T; Chino Y; Ishii W; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
Arthritis Rheum; 2007 Jul; 56(7):2160-9. PubMed ID: 17599736
[TBL] [Abstract][Full Text] [Related]
6. Androgens regulate the binding of endogenous HuR to the AU-rich 3'UTRs of HIF-1alpha and EGF mRNA.
Sheflin LG; Zou AP; Spaulding SW
Biochem Biophys Res Commun; 2004 Sep; 322(2):644-51. PubMed ID: 15325278
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding protein HuR is required for stabilization of SLC11A1 mRNA and SLC11A1 protein expression.
Xu YZ; Di Marco S; Gallouzi I; Rola-Pleszczynski M; Radzioch D
Mol Cell Biol; 2005 Sep; 25(18):8139-49. PubMed ID: 16135804
[TBL] [Abstract][Full Text] [Related]
8. Expression of TNF-alpha, tristetraprolin, T-cell intracellular antigen-1 and Hu antigen R genes in synovium of patients with rheumatoid arthritis.
Suzuki E; Tsutsumi A; Sugihara M; Mamura M; Goto D; Matsumoto I; Ito S; Ikeda K; Ochiai N; Sato Y; Sumida T
Int J Mol Med; 2006 Aug; 18(2):273-8. PubMed ID: 16820934
[TBL] [Abstract][Full Text] [Related]
9. Activity-dependent expression of ELAV/Hu RBPs and neuronal mRNAs in seizure and cocaine brain.
Tiruchinapalli DM; Caron MG; Keene JD
J Neurochem; 2008 Dec; 107(6):1529-43. PubMed ID: 19014379
[TBL] [Abstract][Full Text] [Related]
10. HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol.
Choi HJ; Yang H; Park SH; Moon Y
Toxicol Appl Pharmacol; 2009 Oct; 240(1):46-54. PubMed ID: 19591856
[TBL] [Abstract][Full Text] [Related]
11. [Aberrant regulation of mRNA 3' untranslated region in cancers and inflammation].
Nguyen-Chi M; Morello D
Med Sci (Paris); 2008 Mar; 24(3):290-6. PubMed ID: 18334178
[TBL] [Abstract][Full Text] [Related]
12. Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR.
Doller A; Pfeilschifter J; Eberhardt W
Cell Signal; 2008 Dec; 20(12):2165-73. PubMed ID: 18585896
[TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.
Saunus JM; French JD; Edwards SL; Beveridge DJ; Hatchell EC; Wagner SA; Stein SR; Davidson A; Simpson KJ; Francis GD; Leedman PJ; Brown MA
Cancer Res; 2008 Nov; 68(22):9469-78. PubMed ID: 19010922
[TBL] [Abstract][Full Text] [Related]
14. Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR.
Kawai T; Lal A; Yang X; Galban S; Mazan-Mamczarz K; Gorospe M
Mol Cell Biol; 2006 Apr; 26(8):3295-307. PubMed ID: 16581801
[TBL] [Abstract][Full Text] [Related]
15. Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer.
Woo HH; Zhou Y; Yi X; David CL; Zheng W; Gilmore-Hebert M; Kluger HM; Ulukus EC; Baker T; Stoffer JB; Chambers SK
Oncogene; 2009 Mar; 28(9):1176-86. PubMed ID: 19151756
[TBL] [Abstract][Full Text] [Related]
16. HuR-SIRT: the hairy world of posttranscriptional control.
Wilusz CJ; Wilusz J
Mol Cell; 2007 Feb; 25(4):485-7. PubMed ID: 17317621
[TBL] [Abstract][Full Text] [Related]
17. HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence.
Ortega AD; Sala S; Espinosa E; González-Barón M; Cuezva JM
Carcinogenesis; 2008 Nov; 29(11):2053-61. PubMed ID: 18687667
[TBL] [Abstract][Full Text] [Related]
18. The Elav-like protein HuR exerts translational control of viral internal ribosome entry sites.
Rivas-Aravena A; Ramdohr P; Vallejos M; Valiente-Echeverría F; Dormoy-Raclet V; Rodríguez F; Pino K; Holzmann C; Huidobro-Toro JP; Gallouzi IE; López-Lastra M
Virology; 2009 Sep; 392(2):178-85. PubMed ID: 19647848
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tristetraprolin during differentiation of 3T3-L1 preadipocytes.
Lin NY; Lin CT; Chen YL; Chang CJ
FEBS J; 2007 Feb; 274(3):867-78. PubMed ID: 17288565
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
